Advertisement
Clinical Therapeutics
Advanced searchSave search
Editorial| Volume 18, ISSUE 1, P55, January 1996

Editorial comment

DOI:https://doi.org/10.1016/S0149-2918(96)80178-0
Editorial comment
Previous ArticleThe tolerability and safety profile of famotidine
Next ArticleErythromycin, clarithromycin, and azithromycin: are the differences real?
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0149-2918(96)80178-0

      Copyright

      © 1996 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX